SNCA and Parkinson disease: ELISA analysis of CSF-derived α-synuclein oligomers and early and highly pathologic forms of α-synuclein aggregates accurately discriminates PD patients from healthy controls and, when combined with SAA, may offer a higher degree of accuracy in diagnosis than SAA results alone [97].